XTX Topco’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

XTX Topco’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,085	Closed	-$275K	–	3389
2025 Q1	$275K	Buy	+2,085	New	+$260K	0.01%	1472
2024 Q3	–	Sell	-20,220	Closed	-$1.38M	–	2719
2024 Q2	$1.38M	Buy	+20,220	New	+$1.4M	0.12%	241
2023 Q4	–	Sell	-9,021	Closed	-$470K	–	2250
2023 Q3	$470K	Buy	+9,021	New	+$526K	0.08%	440
2023 Q2	–	Sell	-7,583	Closed	-$411K	–	1929
2023 Q1	$411K	Buy	+7,583	New	+$367K	0.09%	425
2022 Q1	–	Sell	-4,031	Closed	-$211K	–	1004
2021 Q4	$211K	Buy	+4,031	New	+$169K	0.12%	346

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

XTX Topco's ITCI Position: Q2 2025 in Review

XTX Topco sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,085 shares — an estimated $275K sold.

XTX Topco first reported a position in ITCI in Q4 2021 and held it in 5 quarters. The position peaked at $1.38M in Q2 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

XTX Topco reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
XTX Topco sold 2,085 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $275K.
XTX Topco first reported a position in Intra-Cellular Therapies Inc. in Q4 2021 and held it in 5 quarters.
XTX Topco's Intra-Cellular Therapies Inc. position peaked at $1.38M in Q2 2024.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.